FDA Reviewers Voice Concerns Over Novel UTI Treatment
MedPage Today) — Ahead of an Antimicrobial Drugs Advisory Committee meeting on Monday, FDA reviewers voiced ongoing concerns about the benefits versus risks of a novel oral antibiotic for the treatment of uncomplicated urinary tract infections…
MedPage Today) — Ahead of an Antimicrobial Drugs Advisory Committee meeting on Monday, FDA reviewers voiced ongoing concerns about the benefits versus risks of a novel oral antibiotic for the treatment of uncomplicated urinary tract infections…
Read More
About Author
